189 related articles for article (PubMed ID: 38622813)
21. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
Carlson GA; Prusiner SB
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
[TBL] [Abstract][Full Text] [Related]
22. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases.
Gonçalves PB; Sodero ACR; Cordeiro Y
Biomolecules; 2021 May; 11(5):. PubMed ID: 34065606
[TBL] [Abstract][Full Text] [Related]
23. Copper in the brain and Alzheimer's disease.
Hung YH; Bush AI; Cherny RA
J Biol Inorg Chem; 2010 Jan; 15(1):61-76. PubMed ID: 19862561
[TBL] [Abstract][Full Text] [Related]
24. The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators.
Chen LL; Fan YG; Zhao LX; Zhang Q; Wang ZY
Bioorg Chem; 2023 Feb; 131():106301. PubMed ID: 36455485
[TBL] [Abstract][Full Text] [Related]
25. Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer's Disease.
Aaseth J; Skalny AV; Roos PM; Alexander J; Aschner M; Tinkov AA
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502369
[TBL] [Abstract][Full Text] [Related]
26. Copper and oxidative stress in the pathogenesis of Alzheimer's disease.
Eskici G; Axelsen PH
Biochemistry; 2012 Aug; 51(32):6289-311. PubMed ID: 22708607
[TBL] [Abstract][Full Text] [Related]
27. d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.
Squitti R; Rossini PM; Cassetta E; Moffa F; Pasqualetti P; Cortesi M; Colloca A; Rossi L; Finazzi-Agró A
Eur J Clin Invest; 2002 Jan; 32(1):51-9. PubMed ID: 11851727
[TBL] [Abstract][Full Text] [Related]
28. Trace element alterations in Alzheimer's disease: A review.
Cilliers K
Clin Anat; 2021 Jul; 34(5):766-773. PubMed ID: 33580904
[TBL] [Abstract][Full Text] [Related]
29. Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating
Squitti R; Ventriglia M; Simonelli I; Bonvicini C; Costa A; Perini G; Binetti G; Benussi L; Ghidoni R; Koch G; Borroni B; Albanese A; Sensi SL; Rongioletti M
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209820
[TBL] [Abstract][Full Text] [Related]
30. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.
Gaeta A; Hider RC
Br J Pharmacol; 2005 Dec; 146(8):1041-59. PubMed ID: 16205720
[TBL] [Abstract][Full Text] [Related]
31. A vicious circle: role of oxidative stress, intraneuronal Abeta and Cu in Alzheimer's disease.
Bayer TA; Schäfer S; Breyhan H; Wirths O; Treiber C; Multhaup G
Clin Neuropathol; 2006; 25(4):163-71. PubMed ID: 16866297
[TBL] [Abstract][Full Text] [Related]
32. Physical Exercise-Induced Myokines in Neurodegenerative Diseases.
Lee B; Shin M; Park Y; Won SY; Cho KS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071457
[TBL] [Abstract][Full Text] [Related]
33. Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.
Fasae KD; Abolaji AO; Faloye TR; Odunsi AY; Oyetayo BO; Enya JI; Rotimi JA; Akinyemi RO; Whitworth AJ; Aschner M
J Trace Elem Med Biol; 2021 Sep; 67():126779. PubMed ID: 34034029
[TBL] [Abstract][Full Text] [Related]
34. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases.
Alam Q; Alam MZ; Sait KHW; Anfinan N; Noorwali AW; Kamal MA; Khan MSA; Haque A
Curr Drug Metab; 2017; 18(9):868-876. PubMed ID: 28758577
[TBL] [Abstract][Full Text] [Related]
35. A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease.
Savelieff MG; Liu Y; Senthamarai RR; Korshavn KJ; Lee HJ; Ramamoorthy A; Lim MH
Chem Commun (Camb); 2014 May; 50(40):5301-3. PubMed ID: 24326305
[TBL] [Abstract][Full Text] [Related]
36. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
37. Acetylcholinesterase inhibitors in Alzheimer's disease influence Zinc and Copper homeostasis.
Giacconi R; Giuli C; Casoli T; Balietti M; Costarelli L; Provinciali M; Basso A; Piacenza F; Postacchini D; Galeazzi R; Fattoretti P; Nisi L; Fabbietti P; Papa R; Malavolta M
J Trace Elem Med Biol; 2019 Sep; 55():58-63. PubMed ID: 31345366
[TBL] [Abstract][Full Text] [Related]
38. Metals in Alzheimer's disease: a systemic perspective.
Squitti R
Front Biosci (Landmark Ed); 2012 Jan; 17(2):451-72. PubMed ID: 22201755
[TBL] [Abstract][Full Text] [Related]
39. Role of metal dyshomeostasis in Alzheimer's disease.
Bonda DJ; Lee HG; Blair JA; Zhu X; Perry G; Smith MA
Metallomics; 2011 Mar; 3(3):267-70. PubMed ID: 21298161
[TBL] [Abstract][Full Text] [Related]
40. Aluminum and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer's disease.
Becaria A; Bondy SC; Campbell A
J Alzheimers Dis; 2003 Feb; 5(1):31-8. PubMed ID: 12590164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
